相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasma
Yosuke Hirotsu et al.
SCIENTIFIC REPORTS (2020)
Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling
Sabrina Weber et al.
CANCERS (2020)
Tumor Testing for Somatic and GermlineBRCA1/BRCA2Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects
Ana Peixoto et al.
FRONTIERS IN ONCOLOGY (2020)
Ultrasensitive amplicon barcoding for next-generation sequencing facilitating sequence error and amplification-bias correction
Ibrahim Ahmed et al.
Scientific Reports (2020)
Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond BRCA1/BRCA2
Ana Barbosa et al.
CANCERS (2020)
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
A. Gonzalez-Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
CADD: predicting the deleteriousness of variants throughout the human genome
Philipp Rentzsch et al.
NUCLEIC ACIDS RESEARCH (2019)
Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics
Jaime Prat et al.
HUMAN PATHOLOGY (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Potential clinical applications of circulating cell-free DNA in ovarian cancer patients
Ana Barbosa et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2018)
Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer
Elizabeth L. Christie et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Ovarian needle aspiration in the diagnosis and management of ovarian masses
Kimberly Nagamine et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
Marilyn M. Li et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic Studies
Pan Zhang et al.
INTERNATIONAL JOURNAL OF GENOMICS (2017)
Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA
G. Gremel et al.
ANNALS OF ONCOLOGY (2016)
Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer
Sandrina Lambrechts et al.
EUROPEAN JOURNAL OF CANCER (2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
M. R. Mirza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Genetic and molecular changes in ovarian cancer
Robert L. Hollis et al.
CANCER BIOLOGY & MEDICINE (2016)
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
Chengliang Dong et al.
HUMAN MOLECULAR GENETICS (2015)
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L. De Mattos-Arruda et al.
ANNALS OF ONCOLOGY (2014)
Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
Sebastien Couraud et al.
CLINICAL CANCER RESEARCH (2014)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Celeste Leigh Pearce et al.
LANCET ONCOLOGY (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2010)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
分享论文
